Page 180 - AI for Good Innovate for Impact
P. 180

AI for Good Innovate for Impact



                      Links

                      C2itech Website: www .C2itech .hk

                      C2i Website: www .C2i .hk


                      2�2     Benefits of the use case

                      •    The platform directly improves global health by accelerating drug discovery and enabling
                           personalized treatments for respiratory diseases, which are among the leading causes of
                           death worldwide.
                      •    Through open-access AI tools and certification programs, the project trains medical
                           professionals in organoid technology, fostering a new generation of researchers
                           equipped to tackle future pandemics.
                      •    By integrating biotech and AI, the platform drives pharmaceutical innovation, setting new
                           standards for drug development and healthcare delivery.
                      •    Collaborations with WHO, Institut Pasteur, and ASEAN health agencies ensure global
                           knowledge sharing and equitable access to AI-driven healthcare solutions, particularly
                           for developing countries.


                      2�3     Future Work

                      •    Data collection
                      •    Model development
                      •    Standards development (AI ethics in organoid research)
                      •    Setup reference tools


                      3      Use case requirements

                      REQ-01: Build Federated AI Network: Establish a secure, privacy-preserving AI network to
                      share organoid data across 10+ hospitals in Asia. This will enable collaborative research while
                      complying with international data protection standards, ensuring equitable access to cutting-
                      edge medical insights.

                      REQ-02:  Develop  Low-Cost  Organoid  Kits:  Create affordable  organoid  cultivation  kits
                      embedded with AI sensors for real-time pathogen detection. These kits will be distributed
                      to underserved regions, democratizing access to advanced diagnostics and personalized
                      medicine.

                      REQ-03: Launch Certification Program: Design and implement an "AI for Organoid Medicine"
                      certification program targeting 1,000 researchers and healthcare professionals by 2026. The
                      program will include online courses, hands-on workshops, and open-access AI tools to foster
                      global expertise in organoid technology.

                      REQ-04: Publish Open-Source AI Models: Release AI models for viral mutation prediction and
                      organoid simulation on GitHub, accompanied by detailed documentation and tutorials. This
                      will empower researchers worldwide to adapt and improve the models for local healthcare
                      challenges.

                      REQ-05: Establish Global Standards: Collaborate with WHO and Institut Pasteur to develop
                      ethical guidelines and technical standards for AI-driven organoid research, ensuring responsible
                      innovation and interoperability across institutions.



                  144
   175   176   177   178   179   180   181   182   183   184   185